Recombinant E. coli for High-Yield Alanine Fermentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for the fermentative production of alanine are not efficient enough to meet the increasing demand of the chemical industry, necessitating an improvement in yield and productivity.
Innovation Solution
A recombinant microorganism of the Escherichia coli family with enhanced activity and expression of the gcvTHP operon, specifically encoding gcvH, gcvP, and gcvT genes, is developed to increase alanine production, along with modifications such as reduced expression of certain genes like pflB, adhE, ldhA, pta, and frdA, and introduction of an alaD gene for improved enzyme activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional fermentation methods are used for alanine production, then the production process is simple, but the yield and productivity are insufficient to meet increasing industrial demand
Solution Approach 1:
The patent applies parameter changes by modifying the genetic parameters of E. coli through multiple gene overexpressions (gcvTHP operon, pflB, adhE, ldhA, pta, frdA, alaD) and deletions (pta, frdA) to optimize metabolic flux toward alanine production, thereby significantly increasing yield and productivity while managing genetic complexity
Solution Approach 2:
The patent creates a composite genetic structure by combining multiple gene modifications within a single microorganism strain. The recombinant E. coli integrates overexpression of gcvTHP operon with modifications of pflB, adhE, ldhA, pta, frdA, and alaD genes, forming a composite genetic system that synergistically enhances alanine production capacity
2Productivity
If the gcvTHP operon expression is enhanced to increase alanine production, then productivity improves, but the metabolic balance and production of other metabolites may be affected
Solution Approach 1:
The patent applies dynamics by creating a dynamic metabolic balance through coordinated overexpression of multiple genes (gcvTHP, pflB, adhE, ldhA, pta, frdA, alaD) that work together to maintain metabolic flux distribution. This dynamic system allows the microorganism to simultaneously optimize alanine production while maintaining production of other metabolites through balanced enzymatic activities
Solution Approach 2:
The patent implements multi-functionality by designing a recombinant E. coli strain that can simultaneously produce multiple metabolites including alanine, pyruvate, succinate, aspartate, malate, lactate, valine, and leucine. The gcvTHP operon and associated gene modifications serve multiple functions in central metabolism, enabling the microorganism to maintain versatile metabolic capabilities while enhancing alanine productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The recombinant microorganism significantly enhances the yield and productivity of alanine, allowing for the production of other related metabolites like pyruvate, succinate, aspartate, malate, lactate, valine, and leucine, thereby addressing the efficiency and productivity issues in alanine production.
Implementation Method 1
a gcvTHP operon encoding each of a gcvH gene, encoding a lipoylprotein of the glycine cleavage complex, a gcvP gene encoding a pyridoxal phosphate-dependent glycine decarboxylase and a gcvT gene encoding a tetrahydrofolate-dependent aminomethyltransferase
Implementation Method 2
having compared to a respective reference microorganism a higher yield and/or productivity of alanine in fermentative production
Data Source
AI summary
The present invention relates to a recombinant microorganism, to a method for producing alanine and to the use of the recombinant microorganism for the fermentative production of alanine.